2021 ESC意见书:急性肺栓塞后最佳随访

2021-12-07 欧洲心脏病学会 Eur Heart J

2021年12月,欧洲心脏病学会(ESC)肺循环和右心室功能工作组以及动脉粥样硬化和血管生物学工作组联合发布了急性肺动脉栓塞后最佳随访意见书。

中文标题:

2021 ESC意见书:急性肺栓塞后最佳随访

英文标题:

Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working

发布机构:

欧洲心脏病学会

发布日期:

2021-12-07

简要介绍:

2021年12月,欧洲心脏病学会(ESC)肺循环和右心室功能工作组以及动脉粥样硬化和血管生物学工作组联合发布了急性肺动脉栓塞后最佳随访意见书。本文主要针对急性肺栓塞(PE)患者的最佳随访提供全面指导,涵盖了患者咨询的多个方面。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ESC意见书:急性肺栓塞后最佳随访.pdf)] GetToolGuiderByIdResponse(projectId=1, id=dc3371c00228e3af, title=2021 ESC意见书:急性肺栓塞后最佳随访, enTitle=Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working, guiderFrom=Eur Heart J, authorId=0, author=, summary=2021年12月,欧洲心脏病学会(ESC)肺循环和右心室功能工作组以及动脉粥样硬化和血管生物学工作组联合发布了急性肺动脉栓塞后最佳随访意见书。, cover=https://img.medsci.cn/20211214/1639463852251_1614372.png, journalId=0, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会,会员超过70000人、提供更新指南、调查数据、组织学术会议,ESC年会是心血管领域最大的会议。下设5个分会(超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会)。提供指南较全面,按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Tue Dec 07 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月,欧洲心脏病学会(ESC)肺循环和右心室功能工作组以及动脉粥样硬化和血管生物学工作组联合发布了急性肺动脉栓塞后最佳随访意见书。本文主要针对急性肺栓塞(PE)患者的最佳随访提供全面指导,涵盖了患者咨询的多个方面。</span></p>, tagList=[TagDto(tagId=17921, tagName=急性肺栓塞)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=17921, guiderKeyword=急性肺栓塞, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3238, appHits=204, showAppHits=0, pcHits=811, showPcHits=3030, likes=5, shares=17, comments=3, approvalStatus=1, publishedTime=Thu Dec 09 17:26:11 CST 2021, publishedTimeString=2021-12-07, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Dec 09 17:16:53 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 21:10:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESC意见书:急性肺栓塞后最佳随访.pdf)])
2021 ESC意见书:急性肺栓塞后最佳随访.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1192513, encodeId=ad2b1192513ac, content= 很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3eb6499947, createdName=ms6000001052688141, createdTime=Fri Feb 11 22:23:54 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079875, encodeId=abae10e9875b9, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=756c6160070, createdName=ms9000001221280138, createdTime=Tue Dec 14 10:38:25 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078657, encodeId=dbd010e865764, content=非常关键的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed292957767, createdName=黄婷婷, createdTime=Fri Dec 10 08:33:59 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2022-02-11 ms6000001052688141

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1192513, encodeId=ad2b1192513ac, content= 很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3eb6499947, createdName=ms6000001052688141, createdTime=Fri Feb 11 22:23:54 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079875, encodeId=abae10e9875b9, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=756c6160070, createdName=ms9000001221280138, createdTime=Tue Dec 14 10:38:25 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078657, encodeId=dbd010e865764, content=非常关键的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed292957767, createdName=黄婷婷, createdTime=Fri Dec 10 08:33:59 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-14 ms9000001221280138

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1192513, encodeId=ad2b1192513ac, content= 很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3eb6499947, createdName=ms6000001052688141, createdTime=Fri Feb 11 22:23:54 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079875, encodeId=abae10e9875b9, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=756c6160070, createdName=ms9000001221280138, createdTime=Tue Dec 14 10:38:25 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078657, encodeId=dbd010e865764, content=非常关键的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed292957767, createdName=黄婷婷, createdTime=Fri Dec 10 08:33:59 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-10 黄婷婷

    非常关键的指南

    0

拓展阅读

2015 急性肺栓塞诊断与治疗中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2016-03-30

急性肺栓塞的危险分层及诊断策略—解读《2008ESC急性肺栓塞诊断治疗指南》

中华医学会呼吸病学分会慢性阻塞性肺疾病学组 · 2009-01-01

2019 AHA科学声明:急性肺栓塞介入治疗—当前状况和新证据发展

美国心脏协会(AHA,American Heart Association) · 2019-11-04

2022 ESC/EAPCI 临床共识声明:急性肺栓塞经皮治疗选择

欧洲心脏病学会(ESC,European Society of Cardiology) · 2022-09-13